Shah Tirth J, Moshirfar Majid, Hoopes Phillip C
University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
John A. Moran Eye Center, Department of Ophthalmology and Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA.
Ophthalmol Ther. 2018 Dec;7(2):211-215. doi: 10.1007/s40123-018-0136-8. Epub 2018 Jun 29.
Our purpose is to present an evidence-based approach, directed primarily towards eye-care specialists, clarifying whether certain drugs should or should not be used in patients with sulfonamide allergy. We conducted a literature search using PubMed to identify the risk of ophthalmic-specific drugs in patients with a self-reported sulfonamide allergy. MeSH key words included "sulfonamide" and "hypersensitivity". Articles specifically geared towards ophthalmic diseases were sought. The evidence illustrates that individuals with sulfonamide allergy are intrinsically predisposed to higher rates of allergic reaction that is not specific towards sulfonamide non-antimicrobials or sulfur-based medications. We provide a simplified algorithm using the 2017 Clinical Guide to Ophthalmic Drugs to help busy eye care clinicians determine whether a certain common ophthalmic medication is safe or unsafe to prescribe in a patient with a "sulfa allergy".
我们的目的是提出一种主要针对眼保健专家的循证方法,以阐明在磺胺类药物过敏患者中某些药物是否应该使用。我们使用PubMed进行文献检索,以确定自我报告有磺胺类药物过敏的患者使用眼科专用药物的风险。医学主题词包括“磺胺类药物”和“超敏反应”。我们寻找专门针对眼科疾病的文章。证据表明,磺胺类药物过敏的个体本质上更容易发生过敏反应,这种过敏反应并非针对磺胺类非抗菌药物或含硫药物。我们使用《2017年眼科药物临床指南》提供了一种简化算法,以帮助忙碌的眼保健临床医生确定在“磺胺过敏”患者中开具某种常见眼科药物是否安全。